Monitoring and treating heart failure (HF) is a challenging condition at any age. Several models, such as Atrial fibrillation, Hemoglobin, Elderly, Abnormal renal parameters, Diabetes mellitus (AHEAD) ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate ...

Patients with therapeutic intensification of pharmacological pressure-unloading therapy had marked improvements in cardiac load, the study found, as demonstrated by reductions in N-terminal pro-B-type ...

While proven to help, primary care clinicians have been slow to use the drugs once considered only for patients with diabetes.

Following the course of lung function in treatment-naïve patients, researchers found that lung function decline does not accelerate prior to mechanical ventilation. Patterns in the decline of lung ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection fraction improved cardiac function and reduced the risks for serious medical ...

Cardiologists and radiation oncologists at Washington University School of Medicine in St. Louis pioneered the use of radiation therapy - a strategy typically used against cancer - to treat patients ...